open access

Vol 25, No 5 (2020)
Case reports
Published online: 2020-09-01
Submitted: 2020-04-06
Get Citation

Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report

Manasa Veluvolu, Mausam Patel, Ganesh Narayanasamy, Thomas Kim
DOI: 10.1016/j.rpor.2020.06.011
·
Rep Pract Oncol Radiother 2020;25(5):760-764.

open access

Vol 25, No 5 (2020)
Case reports
Published online: 2020-09-01
Submitted: 2020-04-06

Abstract

We review a case of inoperable early stage breast cancer treated definitively with the use of stereotactic ablative radiotherapy (SABR). A 57-year-old female with a history of decompensated cirrhosis with early stage breast cancer was treated with 25 Gy in one fraction. At her 7-month follow up visit, there was a complete resolution of disease on imaging. This case represents a novel approach for the treatment of breast cancer with SABR when surgery is contraindicated.

Abstract

We review a case of inoperable early stage breast cancer treated definitively with the use of stereotactic ablative radiotherapy (SABR). A 57-year-old female with a history of decompensated cirrhosis with early stage breast cancer was treated with 25 Gy in one fraction. At her 7-month follow up visit, there was a complete resolution of disease on imaging. This case represents a novel approach for the treatment of breast cancer with SABR when surgery is contraindicated.

Get Citation

Keywords

SABR; SBRT; Breast; Definitive; Case

About this article
Title

Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 25, No 5 (2020)

Pages

760-764

Published online

2020-09-01

DOI

10.1016/j.rpor.2020.06.011

Bibliographic record

Rep Pract Oncol Radiother 2020;25(5):760-764.

Keywords

SABR
SBRT
Breast
Definitive
Case

Authors

Manasa Veluvolu
Mausam Patel
Ganesh Narayanasamy
Thomas Kim

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl